Refashioning dexpramipexole: A new horizon in eosinophilic asthma?

  • J Allergy Clin Immunol. 2023 Nov;152(5):1092-1094. doi: 10.1016/j.jaci.2023.09.019.
Ruth P Cusack  1 ,  Ibrahim Sulaiman  2 ,  Gail M Gauvreau  3
Affiliations
  • 1. Department of Respiratory Medicine, Galway University Hospitals, Galway, Ireland.
  • 2. Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, Cave Hill, Barbados.
  • 3. Faculty of Health Sciences, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: [email protected].
PMID: 37769877 DOI: 10.1016/j.jaci.2023.09.019
Keywords
Eosinophilic asthma; clinical trial; dexpramipexole; eosinophils.
Products